No pCR in Patients After Neoadjuvant Chemotherapy in TNBC

No pCR in Patients After Neoadjuvant Chemotherapy in TNBC

What to do in patients with early-stage TNBC who have not achieved a pCR?Подробнее

What to do in patients with early-stage TNBC who have not achieved a pCR?

The predictive value of treatment response after neoadjuvant therapyПодробнее

The predictive value of treatment response after neoadjuvant therapy

Neoadjuvant chemotherapy for breast cancer - Time to rethink. 27Jul22Подробнее

Neoadjuvant chemotherapy for breast cancer - Time to rethink. 27Jul22

2022 West Oncology Conference | Breast Cancers | Early-StageПодробнее

2022 West Oncology Conference | Breast Cancers | Early-Stage

Imaging of neo adjuvant therapy in breast cancer treatmentПодробнее

Imaging of neo adjuvant therapy in breast cancer treatment

Evaluation of Breast Specimens after Neoadjuvant ChemotherapyПодробнее

Evaluation of Breast Specimens after Neoadjuvant Chemotherapy

Management of axilla after neo-adjuvant treatmentПодробнее

Management of axilla after neo-adjuvant treatment

Triple Negative Breast Cancer - O'ReganПодробнее

Triple Negative Breast Cancer - O'Regan

pCR associated with significantly reduced risks of EFS eventsПодробнее

pCR associated with significantly reduced risks of EFS events

Prediction of pCR by HRD after Carboplatin Neoadjuvant Chemotherapy in TNBC PatientsПодробнее

Prediction of pCR by HRD after Carboplatin Neoadjuvant Chemotherapy in TNBC Patients

Steps for patients who do not receive complete response after neoadjuvant therapyПодробнее

Steps for patients who do not receive complete response after neoadjuvant therapy

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant TherapyПодробнее

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant Therapy

Neelima Denduluri, MD -- Treatment of Triple Negative Breast CancerПодробнее

Neelima Denduluri, MD -- Treatment of Triple Negative Breast Cancer